OR4E2
Olfactory receptor 4E2
Also known as: OR4E2_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8NGC2
- Gene
- OR4E2
- Canonical length
- 313 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for OR4E2 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
313 residues, UniProt reviewed canonical sequence.
>Q8NGC2|OR4E2
1 MDSLNQTRVT EFVFLGLTDN RVLEMLFFMA FSAIYMLTLS GNILIIIATV FTPSLHTPMY
61 FFLSNLSFID ICHSSVTVPK MLEGLLLERK TISFDNCITQ LFFLHLFACA EIFLLIIVAY
121 DRYVAICTPL HYPNVMNMRV CIQLVFALWL GGTVHSLGQT FLTIRLPYCG PNIIDSYFCD
181 VPLVIKLACT DTYLTGILIV TNSGTISLSC FLAVVTSYMV ILVSLRKHSA EGRQKALSTC
241 SAHFMVVALF FGPCIFIYTR PDTSFSIDKV VSVFYTVVTP LLNPFIYTLR NEEVKSAMKQ
301 LRQRQVFFTK SYTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR4E2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 0 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
- blood vessel: 0 nTPM
Single-cell type
- early spermatids: 3.3 nCPM
- cholangiocytes: 2 nCPM
- late primary spermatocytes: 0.3 nCPM
- podocytes: 0.3 nCPM
- b-cells: 0.2 nCPM
- breast secretory cells: 0.2 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 0.8 nTPM
- cerebral cortex: 0.7 nTPM
- basal ganglia: 0.6 nTPM
- hippocampal formation: 0.6 nTPM
- amygdala: 0.5 nTPM
- pons: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.73
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR4E2 as an antibody target. Whether an autoantibody or antibody against OR4E2 could matter depends on whether native OR4E2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR4E2 is annotated at the cell surface, where native OR4E2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR4E2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...